ARTICLE | Clinical News
CytRx preclinical data
March 23, 2009 7:00 AM UTC
In a rat model of diabetes, iroxanadine improved diabetic peripheral neuropathy as measured by sensory nerve conduction velocity (SCNV) and compound muscle action potential (CMAP) latency. The small m...